Brief: Gracell Biotechnologies Announces Multiple Advancements Of Truucar Allogeneic Car-T Platform
22/02/2022 12:32
Feb 22 (Reuters) - Gracell Biotechnologies Inc GRCL.O :
* GRACELL BIOTECHNOLOGIES ANNOUNCES MULTIPLE ADVANCEMENTS OF
TRUUCAR ALLOGENEIC CAR-T PLATFORM
Source text for Eikon: ID:nPn4cNGJ6a
Further company coverage: GRCL.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Gracell Biotechnologies
See all newsBrief: Gracell Biotechnologies Announces Shareholders’ Approval Of Merger Agreement
Brief: Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
Newscasts - UK Day Ahead: European shares start last week of 2023 on strong footing
Live Markets: European futures rise after holiday break
Press Digest: British Business - Dec 27